Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bart Spiessens

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Asia-Pacific Journal of Clinical Oncology|August 14, 2016
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patientsSzu-Hua Pan, Kang-Yi Su, Bart Spiessens, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 17, 2022
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in JapanTetsuya Matsumoto, Hiroshige Mikamo, Hiroki Ohge, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2024
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational studyJoachim Doua, Miquel Ekkelenkamp, Theo Verheij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance StudiesEveline Weerdenburg, Todd Davies, Brian Morrow, et al.
Vaccine|September 4, 2025
Adopting the estimand framework in prophylactic vaccine trialsFrancois Beckers, Naveen Karkada, Ye Yang, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2024
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli diseaseEnya Arconada Nuin, Tuba Vilken, Basil Britto Xavier, et al.
Epidemiology and Infection|September 3, 2025
A Retrospective Global Study of the Prevalence of O-serotypes of Invasive <i>Escherichia coli</i> Disease in Patients Admitted to Tertiary Care HospitalsJeroen Geurtsen, Joachim Doua, Luis Martinez-Martinez, et al.
NPJ Vaccines|November 30, 2022
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against EbolaViki Bockstal, Maarten Leyssen, Dirk Heerwegh, et al.
Infection|January 24, 2024
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational studyJoachim Doua, Jesús Rodríguez-Baño, Rachel Froget, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Asia-Pacific Journal of Clinical Oncology|August 14, 2016
Gene expression of MAGE-A3 and PRAME tumor antigens and EGFR mutational status in Taiwanese non-small cell lung cancer patientsSzu-Hua Pan, Kang-Yi Su, Bart Spiessens, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|July 17, 2022
Distribution of extraintestinal pathogenic Escherichia coli O-serotypes and antibiotic resistance in blood isolates collected from patients in a surveillance study in JapanTetsuya Matsumoto, Hiroshige Mikamo, Hiroki Ohge, et al.
European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology|January 18, 2024
Feasibility of tracking invasive Escherichia coli disease among older adults in a community setting: A prospective observational studyJoachim Doua, Miquel Ekkelenkamp, Theo Verheij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 10, 2022
Global Distribution of O Serotypes and Antibiotic Resistance in Extraintestinal Pathogenic Escherichia coli Collected From the Blood of Patients With Bacteremia Across Multiple Surveillance StudiesEveline Weerdenburg, Todd Davies, Brian Morrow, et al.
Vaccine|September 4, 2025
Adopting the estimand framework in prophylactic vaccine trialsFrancois Beckers, Naveen Karkada, Ye Yang, et al.
The Journal of Antimicrobial Chemotherapy|July 13, 2024
A microbiological and genomic perspective of globally collected Escherichia coli from adults hospitalized with invasive E. coli diseaseEnya Arconada Nuin, Tuba Vilken, Basil Britto Xavier, et al.
Epidemiology and Infection|September 3, 2025
A Retrospective Global Study of the Prevalence of O-serotypes of Invasive <i>Escherichia coli</i> Disease in Patients Admitted to Tertiary Care HospitalsJeroen Geurtsen, Joachim Doua, Luis Martinez-Martinez, et al.
NPJ Vaccines|November 30, 2022
Non-human primate to human immunobridging demonstrates a protective effect of Ad26.ZEBOV, MVA-BN-Filo vaccine against EbolaViki Bockstal, Maarten Leyssen, Dirk Heerwegh, et al.
Infection|January 24, 2024
Clinical presentation and antimicrobial resistance of invasive Escherichia coli disease in hospitalized older adults: a prospective multinational observational studyJoachim Doua, Jesús Rodríguez-Baño, Rachel Froget, et al.
BMJ Open|March 9, 2022
Protocol for a phase 3 trial to evaluate the effectiveness and safety of a heterologous, two-dose vaccine for Ebola virus disease in the Democratic Republic of the CongoDeborah Watson-Jones, Hugo Kavunga-Membo, Rebecca F Grais, et al.
Pageof 4